ABL Bio shares jumped over 10% after announcing a paid-in capital increase targeting Eli Lilly, following a $2.6 billion ADC platform licensing deal, signaling strengthened partnership and investor confidence.
#YonhapInfomax #ABLBio #EliLilly #PaidInCapitalIncrease #TechnologyTransfer #ADCPlatform #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=90894
#elililly
Celltrion has completed all regulatory reviews for its acquisition of Eli Lilly’s US manufacturing facility, paving the way for expanded biopharmaceutical production and CMO business growth.
#YonhapInfomax #Celltrion #EliLilly #AntitrustReview #ManufacturingFacility #700BillionWonInvestment #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=90145
Trump Unveils Medicare Deal to Cut Weight-Loss Drug Costs as Executive Collapses http://dlvr.it/TP6w7s #BreakingNews #DonaldTrump #EliLilly #NovoNordisk
Media Ushered Out Of Oval Office After Man Collapses During Trump Announcement On Weight Loss Drug Discounts
#News #Politics #DonaldTrump #ElectionLine #EliLilly #Ozempic #Weightlossdrugs
https://deadline.com/2025/11/trump-weight-loss-drug-discounts-1236609242/
Eli Lilly investeert €2,6 miljard in een fabriek voor #medicijnen in Nederland. Europese patiënten betalen nog steeds hoge prijzen, terwijl Amerikaanse prijzen worden verlaagd. Zo verdient #EliLilly de investering terug. https://ap.lc/KDRof
Farmaceut Eli Lilly uit VS bouwt miljardenfabriek met 500 banen in Katwijk
https://www.transport-online.nl/104858/farmaceut-eli-lilly-uit-vs-bouwt-miljardenfabriek-met-500-banen-in-katwijk/ #EliLilly #farmaceut #Karremans #Katwijk
Morgan Stanley expects US healthcare stocks to rebound strongly, citing sector catalysts, major investments by Eli Lilly and AstraZeneca, tariff protection, AI adoption, and a 30% valuation discount to the S&P 500.
#YonhapInfomax #MorganStanley #HealthcareStocks #SP500 #EliLilly #AstraZeneca #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=88849
Celltrion has secured Irish regulatory approval to acquire Eli Lilly’s US manufacturing plant, with only US clearance pending, aiming to boost global competitiveness and accelerate investment recovery.
#YonhapInfomax #Celltrion #EliLilly #MergerApproval #Biopharmaceutical #CMORevenue #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=88770
Eli Lilly shares climbed nearly 4% in pre-market trading after the US pharmaceutical giant reported Q3 earnings and revenue that beat expectations, driven by strong demand for Zepbound and Mounjaro, and raised its 2025 revenue outlook.
#YonhapInfomax #EliLilly #Q3Earnings #Zepbound #Mounjaro #RevenueGuidance #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=88449
Eli Lilly Taps Nvidia to Build Pharma’s Most Powerful AI Supercomputer for Drug Discovery
#AI #Nvidia #EliLilly #Healthcare #Supercomputer #Biotech #DrugDiscovery #Pharma #Innovation #AIinHealthcare #DeepLearning #LifeSciences #Tech
California to sell affordable insulin under state label starting Jan. 1
LOS ANGELES (AP) — Gov. Gavin Newsom said Thursday that California will begin selling affordable insulin under its…
#NewsBeep #News #Headlines #Business #California #ChrisNoble #diabetes #EliLilly #GavinNewsom #Generalnews #Health #Healthcarecosts #Medication #Nonprofits #Prescriptiondrugs #U.S.news #UnitedStates #Us #USA
https://www.newsbeep.com/190761/
Latest News: TG: Another huge investment for Telangana
https://vaartha.com/telangana/another-huge-investment-for-telangana/560097/
#TelanganaInvestment #EliLilly #PharmaInvestment #Hyderabad #TelanganaGrowth #IndustrialExpansion #GlobalPharma #InnovationHub #EconomicBoost #JobCreation #GenomeValley #AdvancedTechnology #BusinessNews #Vaartha #TelanganaNews #Investment2025 #Manufacturing #HealthcareIndustry #TechInfrastructure
Trump empuja a las farmacéuticas a subir los precios de los medicamentos en Europa para bajarlos en EE UU
Celltrion acquires Eli Lilly's US biopharma plant for $340 million, with JP Morgan and Deutsche Bank as exclusive advisors, highlighting global IBs' growing role in cross-border M&A amid shifting supply chains.
#YonhapInfomax #Celltrion #EliLilly #JPMorgan #DeutscheBank #CrossBorderMA #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=83663
Pharmaceutical corporation Eli Lilly and Company plans to build a $6.5 billion manufacturing hub near Lake Houston, the company announced Tuesday.
#Business #HealthScience #Houston #Local #MedicineWellness #News #EliLilly #GovGregAbbott #LakeHouston #PharmaceuticalCompanies #WeightLoss #WeightLossDrugs
Celltrion will acquire Eli Lilly’s New Jersey biopharmaceutical plant for 460 billion won ($335 million), investing at least 1.4 trillion won ($1.02 billion) to expand US production capacity and fully eliminate tariff risks, with operations set to begin in 2027 pending regulatory approval.
#YonhapInfomax #Celltrion #EliLilly #BiopharmaceuticalPlant #TariffRisk #InvestmentAmount #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=82977
Eli Lilly will invest $5 billion in a new Virginia plant, expanding U.S. manufacturing in response to Trump's proposed pharmaceutical import tariffs.
#YonhapInfomax #EliLilly #VirginiaPlant #PharmaceuticalTariffs #USManufacturing #5BillionInvestment #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=82069
Novo Nordisk will cut 9,000 jobs globally, about 11.5% of its workforce, as weak earnings and restructuring prompt a downward revision of its profit outlook.
#YonhapInfomax #NovoNordisk #Wegovy #JobCuts #OperatingProfit #EliLilly #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=81116
Chinese companies are racing to make generic versions of popular branded weight-loss drugs after regulators restricted sale of cheap copies, slowing demand for raw ingredients the firms supplied over the past two years. https://www.japantimes.co.jp/business/2025/09/03/companies/chinese-companies-generics-us-weight/?utm_medium=Social&utm_source=mastodon #business #companies #china #pharmaceuticals #wegovy #elililly #novonordisk #fda
Client Info
Server: https://mastodon.social
Version: 2025.07
Repository: https://github.com/cyevgeniy/lmst